Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1994-11-09
1998-06-09
Hendricks, Keith D.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 232, 435233, 530350, C12N 1512
Patent
active
057635900
ABSTRACT:
An FK506 binding protein of mammalian origin of approximate size (M.sub.r) 52,000, isolated by FK506 affinity chromatography and a corresponding human cDNA of approximate size 2.2 Kb, isolated by screening a human placenta cDNA library with a DNA probe whose sequence predicts a consensus amino acid sequence present in five FKBP12 sequences and in the human FKBP13 sequence.
REFERENCES:
Harding, M.W., et al., "Isolation and Amino Acid Sequence of Cyclophilin", Jour. of Biol. Chem., 261(18), pp. 8547-8555 (1986).
Sawada, S., et al., "Novel Immunosuppressive Agent, FK506 In Vitro Effects on the Cloned T Cell Activation", Jour. of Immun., 139(6), pp. 1797-1803 (1987).
Warty, V., et al., "FK506: A Novel Immunosuppressive Agent Characteristics of Binding and Uptake by Human Lymphocytes", Transpl., 46, pp. 453-455 (1988).
Siekierka, J.J., et al., "A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin", Nature, 341, pp. 755-757 (1989).
Harding, M.W., et al., "A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase", Nature, 341, pp. 758-760 (1989).
Dumont, F.J., et al., "The immunosuppressive macrolides FK-506 and Rapamycin act as reciprocal antagonists in murine T cells", J. of Immun., 144(4), pp. 1418-1424 (1990).
Siekierka, J.J., et al., "The cytosolic-binding protein for the immunosuppressant FK-506 is both a Ubiquitos and Highly Conserved Peptidyl-Prolyl Cis-Trans Isomerase", J. of Biol. Chem., 265(34), pp. 21011-21015 (1990).
Harrison, R.K., et al., "Substrate Specificities of the Peptidyl Prolyl Cis-Trans Isomerase Activities . . . Family of Distinct Enzymes", Biochem., 29(16), pp. 3813-3816 (1990).
Standaert, R.F., et al., "Molecular cloning and overexpression of the human FK506-binding protein FKBP", Nature, 346, pp. 671-674 (1990).
Schreiber, S.L., "Chemistry and Biology of the Immunophilins and their Immunosuppressive Ligands", Science, 251, pp. 283-287 (1991).
Fretz, H., et al., "Rapamycin and FK506 Binding Proteins (Immunophilins)", J. Am. Chem. Soc., 113, pp. 1409-1411 (1991).
Michnick, S.W., et al., "Solution Structure of FKBP, a Rotamase Enzyme and Receptor for FK506 and Rapamycin", Science, 252, pp. 836-839 (1991).
Van Duyne, G.D., et al., "Atomic Structure of FKBP-FK506, an Immunophilin-Immunosuppressant Complex", Science, 252, pp. 839-842 (1991).
Moore, J.M., et al., "Solution structure of the major binding protein for the immunosuppressant FK506", Nature, 351, pp. 248-250 (1991).
Liu, J., et al., "Calcineurin is a common target of cyclophilin-Cyclosporin A and FKBP-FP506 Complexes", Cell, pp. 807-815 (1991).
Jin, Y-J., et al., "Molecular cloning of a membrane-associated human FK506-and Rapamycin-binding protein, FKBP-13", Proc. Natl. Acad. Sci. USA, 88, pp. 6677-6681 (1991).
Rosborough, S.L., et al., "Identification of FKBP-Related Proteins with Antibodies of Predetermined Specificity and Isolation by FK506 Affinity Chromatography", Trans. Proc., 23(6), pp. 2890-2893 (1991).
Palaszynski et al., "Purification and Characterization of Cyclosporine and FK-506 Binding Proteins From A Human T-Helper Cell Line," Clin Biochem, 24, pp. 63-70 (1991).
Donnelly et al., "Cyclosprine, FK-506, and Rapamycin Interactions With A Cytosolic Binding Protein," FASEB J., 5, Abs. 2092 (1991).
Donnelly et al., "Purification of a 50- to 58kDa Immunophilin from Human Spleen and a Jurkat T-Cell Line Capable of Binding Cyclosporine A, FK 506, and Rapamycin," Transplant Proc., 23, pp. 2886-2889 (1991).
Donnelly et al., "Cyclosporine and FK 506 May Share A Common Cytosolic Binding Protein," Clin. Chem., 36(6), Abs. 0384 (1990).
Donnelly et al., "Cyclosporin G and Metabolite Binding to Cyclophilin and a 50 kDa Binding Protein Related to In Vitro Immunosuppression", Clin. Biochem, 39, pp. 122-125 (1993).
Donnelly, J.G., "Purification and Characterization of a 50 kDa Lymphocyte-Derived Binding Protein for Cyclosporin, FK 506 and Rapamycin", Doctoral Thesis, George Washington University, pp. 182-183, 190 (1993).
Sanchez et al., Biochemistry, vol. 29:5145-5152, 1990.
Lathe, R., J. Mol. Biol., vol. 183:1-12, 1985.
Sambrook et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Press, pp. 11.3-11.19, 1989.
Harding Matthew W.
Livingston David J.
Peattie Debra A.
Haley, Jr. James F.
Hendricks Keith D.
Pierri Margaret A.
Vertex Pharmaceuticals Inc.
LandOfFree
Isolation of an M.sub.r 52,000 FK506 binding protein and molecul does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolation of an M.sub.r 52,000 FK506 binding protein and molecul, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolation of an M.sub.r 52,000 FK506 binding protein and molecul will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2200663